Breast cancer risk among women under 55 years of age by joint effects of usage of oral contraceptives and hormone replacement therapy

Menopause

Volumn 5, Issue 3, 1998, Pages 145-151

  Brinton, Louise A ^a   Brogan, Donna R ^b   Coates, Ralph J ^c   Swanson, Christine A ^a   Potischman, Nancy ^a   Stanford, Janet L ^d  

^a NATIONAL CANCER INSTITUTE   (United States)

^b EMORY UNIVERSITY   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Breast cancer; Hormone replacement therapy; Oral contraceptives; Risk

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; BREAST CANCER; CANCER RISK; CONTROLLED STUDY; FEMALE; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; ORAL CONTRACEPTION;

ADULT; AGE FACTORS; BODY CONSTITUTION; BODY WEIGHT; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CONTINENTAL POPULATION GROUPS; CONTRACEPTIVES, ORAL; ESTROGEN REPLACEMENT THERAPY; FEMALE; GEORGIA; HUMANS; MENOPAUSE; MIDDLE AGED; RISK FACTORS;

EID: 0031670933     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Brinton LA. Hormone replacement therapy and risk for breast cancer. Endocrinol Metab Clin North Am 1997;26:361-78.
2. Bergkvist L, Adami H-O, Persson I, Hoover R, Schairer C. The risk of breast cancer after estrogen and estrogen-progestin replacement. N Engl J Med 1989;321:293-7.
3. Brinton LA, Hoover R, Fraumeni JF Jr. Menopausal oestrogens and breast cancer risk: an expanded case-control study. Br J Cancer 1986;54:825-32.
4. Ewertz M. Influence of non-contraceptive exogenous and endogenous sex hormones on breast cancer risk in Denmark. Int J Cancer 1988;42:832-8.
5. Hoover R, Glass A, Finkle WD, Azevedo D, Milne K. Conjugated estrogens and breast cancer risk in women. J Natl Cancer Inst 1981;67:815-20.
6. Hoover R, Gray LA, Cole P, MacMahon B. Menopausal estrogens and breast cancer. N Engl J Med 1976;295:401-5.
7. Hulka BS, Chambless LE, Deubner DC, Wilkinson WE. Breast cancer and estrogen replacement therapy. Am J Obstet Gynecol 1982;143:638-44.
8. La Vecchia C, Negri E, Franceschi S, et al. Hormone replacement treatment and breast cancer risk: a cooperative Italian study. Br J Cancer 1995;72:244-48.
9. Risch HA, Howe GR. Menopausal hormone usage and breast cancer in Saskatchewan: a record-linkage cohort study. Am J Epidemiol 1994;139:670-83.
10. Rohan TE, McMichael AJ. Non-contraceptive exogenous oestrogen therapy and breast cancer. Med J Austral 1988;148:217-21.
11. Colditz GA, Hankinson SE, Hunter DJ, et al. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med 1995;332:1589-93.
12. Mills PK, Beeson L, Phillips RL, Fraser GE. Prospective study of exogenous hormone use and breast cancer in Seventh-Day Adventists. Cancer 1989;64:591-7.
13. Yang CP, Daling JR, Band PR, Gallagher RP, White E, Weiss NS. Noncontraceptive hormone use and risk of breast cancer. Cancer Causes Control 1992;3:475-9.
14. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet 1997;350:1047-59.
15. Brinton LA, Daling JR, Liff JM, et al. Oral contraceptives and breast cancer risk among younger women. J Natl Cancer Inst 1995;87:827-35.
16. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53,297 women with breast cancer and 100,239 women without breast cancer from 54 epidemiological studies. Lancet 1996;347:1713-27.
17. UK National Case-Control Study. Oral contraceptive use and breast cancer risk in young women. Lancet 1989;6:973-82.
18. White E, Malone KE, Weiss NS, et al. Breast cancer among young US women in relation to oral contraceptive use. J Natl Cancer Inst 1994;86:505-14.
19. Waksberg J. Sampling methods for random digit dialing. J Am Stat Assoc 1978;73:40-6.
20. Breslow NE, Day NE. Statistical methods in cancer research. Volume 1 - the analysis of case-control studies. IARC Sci Publ 1980;32:5-338.
21. Colditz GA, Stampfer MJ, Willett WC, et al. Type of postmenopausal hormone use and risk of breast cancer: 12-year follow-up from the Nurses' Health Study. Cancer Causes Control 1992;3:433-9.
22. Schuurman AG, van den Brandt PA, Goldbohm RA. Exogenous hormone use and the risk of postmenopausal breast cancer: Results from the Netherlands cohort study. Cancer Causes Control 1995;6:416-24.
23. Stanford JL, Brinton LA, Hoover RN. Oral contraceptives and breast cancer: Results from an expanded case-control study. Br J Cancer 1989;60:375-81.
24. Stanford JL, Weiss NS, Voigt LF, Daling JR, Habel LA, Rossing MA. Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle aged women. JAMA 1995;274:137-12.
25. Kaufman DW, Palmer JR, de Mouzon J, et al. Estrogen replacement therapy and the risk of breast cancer: results from the case-control surveillance study. Am J Epidemiol 1991;134:1375-85.
26. Palmer JR, Rosenberg L, Clarke EA, Miller DR, Shapiro S. Breast cancer risk after estrogen-replacement therapy: results from the Toronto breast cancer study. Am J Epidemiol 1991;34:1386-95.
27. Wingo PA, Layde PM, Lee NC, Rubin G, Ory HW. The risk of breast cancer in postmenopausal women who have used estrogen replacement therapy. JAMA 1987;257:209-15.
28. Miller DR, Rosenberg L, Kaufman DW, et al. Breast cancer before age 45 and oral contraceptive use: new findings. Am J Epidemiol 1989;129:269-80.
29. Rosenberg L, Palmer JR, Rao RS, et al. Case-control study of oral contraceptive use and risk of breast cancer. Am J Epidemiol 1996;143:25-37.
30. Newcomb PA, Longnecker MP, Storer BE, et al. Long-term hormone replacement therapy and risk of breast cancer in post-menopausal women. Am J Epidemiol 1995;142:788-95.
31. Nomura AMY, Kolonel LN, Hirohata T, Lee J. The association of replacement estrogens with breast cancer. Int J Cancer 1986;37:49-53.
32. Huang Z, Hankinson SE, Colditz GA, et al. Dual effects of weight and weight gain on breast cancer risk. JAMA 1997;278:1407-11.